Article: Investigators at Yale University zero in on addiction medicine.

Current study results from the report, 'Cholinergic functioning in stimulant addiction: implications for medications development,' have been published. "Acetylcholine, the first neurotransmitter discovered, participates in many CNS functions, including sensory and motor processing, sleep, nociception, mood, stress response, attention, arousal, memory, motivation and reward. These diverse cholinergic effects are mediated by nicotinic-and muscarinic-type cholinergic receptors (nAChR and mAChR, respectively)," scientists in the United States report (see also Addiction Medicine).

"The goal of this review is to synthesize a growing literature that supports the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!